Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept studyFederica Miglietta, Valentina Guarneri, Andrea Botticelli et al.|ESMO Open|2024Cited by 7
4MO_PR HER2-low breast cancer: Evolution from primary breast cancer to relapseFederica Miglietta, Maria Vittoria Dieci, Gaia Griguolo et al.|Annals of Oncology|2021Cited by 1
211P ER-low breast cancer: Evolution from primary tumor to relapse and prognostic impactFederica Miglietta, Maria Vittoria Dieci, Daniela Iannaccone et al.|ESMO Open|2023Cited by 1
212P HER2-low breast cancer: Evolution from primary tumor to residual disease after neoadjuvant treatmentFederica Miglietta, Maria Vittoria Dieci, Gaia Griguolo et al.|Annals of Oncology|2021Cited by 0